$AXTI

AXT Inc. (NASDAQ: AXTI) trust plans 2,000-share sale in Form 144 filing

AXT Inc. (NASDAQ: AXTI) says an affiliate, Leblanc Living Trust, plans to sell up to 2,000 Class A shares on or about 08/07/2026 via broker Purshe Kaplan Sterling. The filing values the planned sale at about $175,020.00. A prior sale of 500 shares on 06/10/2026 generated $44,705.07.

Original reporting
Published Aug 7, 2026, 6:43 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 2:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$AXTI
Neutral
medium confidence
Mentioned
$AXTI
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$AXTINeutralLow
01

Why it matters

The main tradable element is the disclosed intent and timing for a small block sale, which can slightly pressure sentiment but is unlikely to change valuation absent larger or repeated selling.

02

Market read

A routine Form 144 disclosure with a small share count, offering limited incremental information for trading beyond near-term sentiment.

03

What to watch

The filing does not state price, execution certainty, or whether additional tranches follow; traders should watch for subsequent filings or larger sale sizes before assuming sustained pressure.

Relevance 4/10Novelty 4/10Timing: on or about 08/07/2026 planned Form 144 sale window

Background

The article summarizes an SEC Form 144 filing for AXT Inc., where an affiliate trust plans to sell shares through a broker on or about 08/07/2026.

Company-level read

Ticker impact

$AXTINeutralMedium confidence
Context

Leblanc Living Trust filed Form 144 to sell up to 2,000 AXT Class A shares on or about 08/07/2026 via Purshe Kaplan Sterling.

Expected impact

Limited near-term impact; any effect would be modest and short-lived unless follow-on selling scales up.

Evidence & confidence

The article discloses a planned sale size (2,000 shares) and prior smaller sale (500 shares), but provides no new operating, financial, or regulatory catalyst. Form 144 indicates intent and timing, which can affect sentiment, yet the disclosed volume is small versus 65.4M shares outstanding.

Market effects

No clear sector read-through; this is a company-specific selling disclosure without operational implications.

None indicated.

None indicated.

Counterpoint

Because Form 144 reflects planned sales that may not fully execute, the market may overreact to the headline selling risk.

Key entities

  • AXT Inc.

    NASDAQ-listed company whose Class A shares are subject to a Form 144 planned sale by an affiliate trust.

  • Leblanc Living Trust

    Affiliate trust planning to sell up to 2,000 Class A shares of AXT via Form 144.

  • Purshe Kaplan Sterling

    Broker named for executing the planned sale.

Related articles

$AXTIMedAI 8/10

AXTI Stock Soars As AI Demand Turns Earnings Corner

AXT Inc (NASDAQ: AXTI) shares rose about 18.6% after the company announced semiconductor capacity expansion tied to AI demand. The article cites Q2 revenue of $47.6M (vs $18.0M a year earlier) and adjusted EPS of $0.19. It also reports Q3 guidance EPS $0.30–$0.32 and revenue about $66M, plus analyst target updates.

$AXTIMedAI 8/10

AXT (AXTI) Q2 2026 Earnings Call Transcript

AXT (AXTI) held its Q2 2026 earnings call, reporting revenue of $47.6M, up 77% vs Q1 2026 and 164% vs Q2 2025. Indium phosphide revenue was $30.7M. Non-GAAP gross margin was 45.0%. Non-GAAP net profit was $11.9M ($0.19/share). Cash rose to $749M after a $632M secondary offering. The company also discussed supply prepayments and a plan to list its Tongmei subsidiary via Hong Kong instead of China’s STAR Market.

$AXTIMed

AXT (AXTI) Stock Jumps As AI Demand Fuels Profit Revival

AXT (AXTI) shares rose 28.7% to $60.43 after the company reported Q2 results. According to AXT, Q2 revenue was $47.6m versus $18.0m a year earlier, with net profit of $11.1m versus a loss, and basic EPS of $0.18. Non-GAAP gross margin rose to 45% from 8.2%, driven by indium phosphide revenue and AI demand.

$AXTIHighAI 9/10

AXT Sees Highest Quarterly Indium Phosphide Revenue Ever - AXT (NASDAQ:AXTI)

AXT Inc. (NASDAQ:AXTI) shares rose premarket after the company reported Q2 results. Adjusted EPS was 19 cents, above the 7-cent consensus. Revenue increased 164.8% Y/Y to $47.59 million versus $34.09 million expected. Indium phosphide revenue reached a record $30.7 million, and Q3 guidance calls for adjusted EPS of 30-32 cents and sales of $66.0 million.

$AXTIMedAI 8/10

AXT: Q2 Earnings Snapshot

FREMONT, Calif. (AP) — FREMONT, Calif. (AP) — AXT Inc. (AXTI) on Thursday reported second-quarter net income of $11.1 million, after reporting a loss in the same period a year earlier. On a per-share basis, the Fremont, California-based company said it had net income of 17 cents. Earnings, adjusted for stock option expense, came to 19 cents per share. The results beat Wall Street expectations.

$AXTIHighAI 9/10

AXT Stock Rips Higher After Q2 Earnings — Here's Why - AXT (NASDAQ:AXTI)

Here’s a look at the details inside the report. AXTI stock is moving. Watch the price action here. AXT Q2 Details Semi wafer manufacturer AXT reported quarterly earnings of 19 cents per share, which beat the analyst consensus estimate of seven cents by 171.43%, according to Benzinga Pro data. Quarterly revenue clocked in at $47.59 million, blowing past the Street estimate of $34.09 million by 39.61%.